Form 4: Elevance Health Executive Charles Morgan Kendrick JR Reports Stock Transactions

Elevance Health's EVP & President, Commercial, Charles Morgan Kendrick JR, reports the acquisition and disposal of company stock on November 1, 2024.

Summary

• Charles Morgan Kendrick JR, an EVP & President, Commercial at Elevance Health, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On November 1, 2024, Kendrick disposed of 846 shares of common stock to cover tax liabilities related to vesting restricted stock at a price of $414.01 per share.
• On the same day, Kendrick acquired 1,710 performance-based restricted share units, which vested on 11/1/2024.
• Following these transactions, Kendrick directly owns 9,287 shares of Elevance Health common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transactions are standard for executive compensation and tax obligations, indicating neither strong positive nor negative signals.

Positives

• The acquisition of 1,710 performance-based restricted share units suggests confidence in the company's future performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they primarily reflect internal compensation adjustments.

Key Dates